These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2680506)

  • 21. Washout of long-term treatment with flecainide and propafenone in patients with complex ventricular arrhythmias and cardiac disease. Antiarrhythmic Drug Evaluation Group.
    Vincenti A; Landolina M; Latini R; Cavalli A; Gaita F; Giani P
    Am Heart J; 1992 Aug; 124(2):374-80. PubMed ID: 1636581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.
    Takanaka C; Nonokawa M; Machii T; Lee S; Kato H; Haruna M; Yabe S
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2130-3. PubMed ID: 1279613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
    Zoble RG; Kirsten EB; Brewington J
    Clin Pharmacol Ther; 1989 May; 45(5):535-41. PubMed ID: 2721109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study.
    Jonason T; Ringqvist I; Bandh S; Nilsson G; Nilsson H; Lidell C; Bjerle P; Olofsson BO
    Acta Med Scand; 1988; 223(6):515-23. PubMed ID: 3291557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propafenone for the treatment of refractory complex ventricular ectopic activity.
    Hammill SC; Sorenson PB; Wood DL; Sugrue DD; Osborn MJ; Gersh BJ; Holmes DR
    Mayo Clin Proc; 1986 Feb; 61(2):98-103. PubMed ID: 3945115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L; Myburgh DP; Schamroth CL; Scholtz ME; Pincus DR; Kawalsky DL
    Chest; 1985 Apr; 87(4):448-51. PubMed ID: 3884286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propafenone in the prevention of non-ventricular arrhythmias associated with the Wolff-Parkinson-White syndrome.
    Vassiliadis I; Papoutsakis P; Kallikazaros I; Stefanadis C
    Int J Cardiol; 1990 Apr; 27(1):63-70. PubMed ID: 2335410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N; Terry L; Murphy ML; Thompson CH; Doherty JE; Sakhaii M; Dinh H
    Am Heart J; 1984 Aug; 108(2):285-9. PubMed ID: 6380253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Huguet R; Wajman A
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1495-505. PubMed ID: 2432845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias.
    Budde T; Borggrefe M; Podczeck A; Martinez-Rubio A; Breithardt G
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):254-60. PubMed ID: 1717787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM; Palmer KJ; Langtry HD; Fitton A
    Drugs; 1993 Jan; 45(1):85-130. PubMed ID: 7680987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of propafenone in congenital junctional ectopic tachycardia.
    Paul T; Reimer A; Janousek J; Kallfelz HC
    J Am Coll Cardiol; 1992 Oct; 20(4):911-4. PubMed ID: 1527301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
    Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic propafenone: improving patient outcomes.
    Brzozowski LA
    Dimens Crit Care Nurs; 1993; 12(3):116-22. PubMed ID: 8508716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma propafenone concentration in the evaluation of anti-arrhythmic efficacy.
    Steurer G; Weber H; Schmidinger H; Plass H; Frey B; Pürerfellner H; Probst P
    Eur Heart J; 1991 Apr; 12(4):526-32. PubMed ID: 2065687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive diagnosis of ventricular arrhythmias by means of ambulatory-ECG monitoring.
    Candinas RA; Podrid PJ
    Herz; 1990 Feb; 15(1):1-10. PubMed ID: 2179087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Brazilian multicenter study of sotalol effectiveness in ventricular arrhythmias].
    Maia IG; Lorga AM; de Paola AA; Rassi A; Perez AK; Sobral D; Atie J; Gizzi JC; Darwich R
    Arq Bras Cardiol; 1996 Mar; 66(3):173-8. PubMed ID: 8762699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.